Skip navigation

Engineering protein toxins to modulate the intracellular trafficking of biologics into exosomes for third order drug targeting

Engineering protein toxins to modulate the intracellular trafficking of biologics into exosomes for third order drug targeting

Feron, Benedita and Richardson, Simon ORCID: 0000-0002-7927-0649 (2022) Engineering protein toxins to modulate the intracellular trafficking of biologics into exosomes for third order drug targeting. European Journal of Extracellular Vesicles, 2. pp. 1-14. ISSN 2001-3078

[img]
Preview
PDF (Publisher VoR)
35660_RICHARDSON_Engineering_protein_toxins_to_modulate.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (792kB) | Preview

Abstract

The successful use of mRNA as a vaccine to limit the effects of COVID-19 has highlighted the potential of RNA based drugs. However, the use of small interfering (si)RNA (or antisense oligonucleotides (ASOs)) as therapeutics remains limited by the availability of safe and robust drug delivery technology that can deliver intact RNA to the cytosol of tissues beyond the liver or muscle. New knowledge regarding the regulation of intracellular compartmentalisation associated with membrane trafficking has led to the identification of new problems and opportunities within the field of drug delivery. One of the technologies that has emerged is the use of attenuated toxins for the cytosolic delivery of macromolecules. Unlike charged lipids or synthetic polymers, these molecules do not display charge limited PKPD or toxicity profiles intimately linked to their ability to mediate transfection. Anthrax toxin uses intraluminal vesicles (ILVs) as an intermediary compartment en route to the cytosol of mammalian cells. These ILVs can be subsequently secreted as exosomes and herein is an opportunity to load selected nucleic acid or protein drugs into exosomes. Exosomes loaded in this manner have the potential to transport bioactive payloads across intercellular space to their target, whilst protecting their luminal cargo from hydrolytic enzymes or from the host’s immune response before effecting cytosolic delivery. Following such a rationale, engineering biology may provide a valuable platform for third order drug targeting and facilitate the intracellular delivery of RNA drugs to cells and tissues beyond striated muscle and the liver.

Item Type: Article
Uncontrolled Keywords: antisense; siRNA; toxin; cytosol; endocytosis; exosomes; biologics
Subjects: Q Science > QD Chemistry
Q Science > QH Natural history > QH301 Biology
Faculty / School / Research Centre / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > School of Science (SCI)
Last Modified: 30 Mar 2022 15:23
URI: http://gala.gre.ac.uk/id/eprint/35660

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics